DxTerity’s objective is to deliver our powerful genomic testing technology into routine medical care across a broad range of diseases and chronic conditions through key strategic partnerships.
Our Clinical Diagnostic Partner program is designed to establish collaborations with key industry partners having existing capability to rapidly commercialize products in their areas of clinical expertise. Disease areas such as organ-specific cancers, cardiovascular disease, and infectious disease identification are targeted opportunities in which testing with DxDirect™ can deliver high clinical value.
Use DxDirect™ to enhance your business and product offerings:
DxTerity Diagnostics opens 10000 Sq Ft Molecular Lab in Rancho Dominguez California read more...
DxTerity Diagnostics Aquires Gene Signature Assets from SourceMDx read more...
Chemistry White Paper read
REDI-Dx RUO White Paper read
FFPE White Paper read
DxCollectTM Sample Collection Product Flyer read
Research Partner Flyer read